{"id":"W2335069544","doi":"10.1016/j.clcc.2016.03.004","title":"A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma","year":2016,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cetuximab; Medicine; Colorectal cancer; Oncology; Internal medicine; Randomized controlled trial; Phosphatidylinositol; Kinase; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001338918,0.00195303,0.003191196,0.0004523053,0.0004928746,0.001096188,0.0009331818,0.001629037,0.006004626],"category_scores_gemma":[0.00122963,0.0009303316,0.00134962,0.0005028477,0.001632449,0.00134502,0.0005200087,0.003536933,0.001113373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009643565,"about_ca_system_score_gemma":0.001608274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001579175,"about_ca_topic_score_gemma":0.003628849,"domain_scores_codex":[0.9995346,0.0002022177,0.00002487015,0.0001007695,0.00003010842,0.0001073268],"domain_scores_gemma":[0.9993411,0.0001381854,0.00009620306,0.00006200322,0.00003113816,0.0003313697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9733356,0.00729704,0.0005983415,0.0002500031,0.0004592393,0.00003827949,0.00004695686,0.0007238925,0.004069407,0.0001239527,0.0006076843,0.01244961],"study_design_scores_gemma":[0.9395497,0.05764126,0.001243018,0.000008971808,0.0002135031,0.00002744651,0.00001906158,0.0004016369,0.0004236978,0.00009894439,0.0003613469,0.00001145817],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921177,0.001462614,0.0004842234,0.0006889331,0.0004383778,0.002224219,0.0005793655,0.00009733347,0.001907183],"genre_scores_gemma":[0.9901261,0.0012433,0.001113172,0.0009623845,0.0002841915,0.001829187,0.001119826,0.00002952582,0.003292193],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006004626,"threshold_uncertainty_score":0.02008748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03115746277251978,"score_gpt":0.3507161003024449,"score_spread":0.3195586375299251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}